Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07314775) titled 'Yangxin Dawayimixike Honey Paste for Carotid Atherosclerotic Plaque With Dyslipidemia: A Randomized Controlled Clinical Study' on Dec. 18, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Xinjiang Uygur Pharmaceutical Co., Ltd.
Condition:
Dyslipidemia
Carotid Atherosclerotic Plaques
Intervention:
Drug: Yangxin Dawayimixike Honey Paste
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: January 2026
Target Sample Size: 422
To kno...